Pharmaceutical innovation, competition and patent law : a trilateral perspective

Resource Information

The work Pharmaceutical innovation, competition and patent law : a trilateral perspective represents a distinct intellectual or artistic creation found in Biddle Law Library. This resource is a combination of several types including: Work, Language Material, Books.

Label

Pharmaceutical innovation, competition and patent law : a trilateral perspective

Title remainder

a trilateral perspective

Statement of responsibility

edited by Josef Drexl, Director, Max Planck Institute for Intellectual Property and Competition Law, Munich, Germanyl; Nari Lee, Professor of Intellectual Property Law, Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki

Contributor

• Drexl, Josef
• Lee, Nari

Editor

• Drexl, Josef
• Lee, Nari

Subject

• Antitrust law -- European Union countries
• Drugs -- Japan -- Patents
• Pharmaceutical industry -- Technological innovations
• Drugs -- European Union countries -- Patents
• Drugs -- United States -- Patents

Genre

• Patents

Language

eng

Summary

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators

Cataloging source

Uk

Index

index present

Literary form

non fiction

Nature of contents

bibliography